Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Assessment of Campbell Score as a Means of Predicting Suicidal Ideation High Risk Patients

NCT04606875 is registered in ClinicalTrials.gov with Therapeutic Solutions International as lead sponsor.

NCT NCT04606875
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04606875 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Assessment of Campbell Score as a Means of Predicting Suicidal Ideation High Risk Patients
Lead sponsor
Therapeutic Solutions International
Phase
Observational
Overall status
Unknown status
Start date
November 5, 2020
Completion date
February 13, 2021
Enrollment
30 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

suicidal ideation